These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
368 related items for PubMed ID: 23762272
1. Combined 5-FU and ChoKα inhibitors as a new alternative therapy of colorectal cancer: evidence in human tumor-derived cell lines and mouse xenografts. de la Cueva A, Ramírez de Molina A, Alvarez-Ayerza N, Ramos MA, Cebrián A, Del Pulgar TG, Lacal JC. PLoS One; 2013; 8(6):e64961. PubMed ID: 23762272 [Abstract] [Full Text] [Related]
2. Combined therapy with a thymidylate synthase-inhibiting vector and S-1 has effective antitumor activity against 5-FU-resistant tumors. Kadota K, Huang CL, Liu D, Yokomise H, Haba R, Wada H. Int J Oncol; 2011 Feb; 38(2):355-63. PubMed ID: 21174056 [Abstract] [Full Text] [Related]
5. Choline kinase inhibition in rheumatoid arthritis. Guma M, Sanchez-Lopez E, Lodi A, Garcia-Carbonell R, Tiziani S, Karin M, Lacal JC, Firestein GS. Ann Rheum Dis; 2015 Jul; 74(7):1399-407. PubMed ID: 25274633 [Abstract] [Full Text] [Related]
6. Correlation between chemosensitivity and mRNA expression level of 5-fluorouracil-related metabolic enzymes during liver metastasis of colorectal cancer. Okumura K, Shiomi H, Mekata E, Kaizuka M, Endo Y, Kurumi Y, Tani T. Oncol Rep; 2006 Apr; 15(4):875-82. PubMed ID: 16525674 [Abstract] [Full Text] [Related]
9. The transfection of thymidylate synthase antisense suppresses oncogenic properties of a human colon cancer cell line and augments the antitumor effect of fluorouracil. Matsuoka K, Tsukuda K, Suda M, Kobayashi K, Ota T, Okita A, Watanabe K, Suzuki E, Murakami M, Doihara H, Shimizu N. Int J Oncol; 2004 Jan; 24(1):217-22. PubMed ID: 14654960 [Abstract] [Full Text] [Related]
10. Metronomic S-1 dosing and thymidylate synthase silencing have synergistic antitumor efficacy in a colorectal cancer xenograft model. Abu Lila AS, Moriyoshi N, Fukushima M, Huang CL, Wada H, Ishida T. Cancer Lett; 2017 Aug 01; 400():223-231. PubMed ID: 27838412 [Abstract] [Full Text] [Related]
11. STAT3 inhibition sensitizes colorectal cancer to chemoradiotherapy in vitro and in vivo. Spitzner M, Roesler B, Bielfeld C, Emons G, Gaedcke J, Wolff HA, Rave-Fränk M, Kramer F, Beissbarth T, Kitz J, Wienands J, Ghadimi BM, Ebner R, Ried T, Grade M. Int J Cancer; 2014 Feb 15; 134(4):997-1007. PubMed ID: 23934972 [Abstract] [Full Text] [Related]
13. Pseudolaric acid B induces mitotic arrest and apoptosis in both 5-fluorouracil-sensitive and -resistant colorectal cancer cells. Wen C, Chen J, Zhang D, Wang H, Che J, Qin Q, He L, Cai Z, Lin M, Lou Q, Huang L, Chen D, Iwamoto A, Ren D, Wang L, Lan P, Wang J, Liu H, Yang X. Cancer Lett; 2016 Dec 28; 383(2):295-308. PubMed ID: 27713084 [Abstract] [Full Text] [Related]
14. Weichang'an and 5-fluorouracil suppresses colorectal cancer in a mouse model. Tao L, Yang JK, Gu Y, Zhou X, Zhao AG, Zheng J, Zhu YJ. World J Gastroenterol; 2015 Jan 28; 21(4):1125-39. PubMed ID: 25632185 [Abstract] [Full Text] [Related]
15. B7-H3 increases thymidylate synthase expression via the PI3k-Akt pathway. Jiang B, Liu F, Liu Z, Zhang T, Hua D. Tumour Biol; 2016 Jul 28; 37(7):9465-72. PubMed ID: 26787540 [Abstract] [Full Text] [Related]
18. Enhanced 5-fluorouracil cytotoxicity in high cyclooxygenase-2 expressing colorectal cancer cells and xenografts induced by non-steroidal anti-inflammatory drugs via downregulation of dihydropyrimidine dehydrogenase. Réti A, Pap E, Adleff V, Jeney A, Kralovánszky J, Budai B. Cancer Chemother Pharmacol; 2010 Jul 28; 66(2):219-27. PubMed ID: 19830428 [Abstract] [Full Text] [Related]
19. Induction of thymidine kinase 1 after 5-fluorouracil as a mechanism for 3'-deoxy-3'-[18F]fluorothymidine flare. Lee SJ, Kim SY, Chung JH, Oh SJ, Ryu JS, Hong YS, Kim TW, Moon DH. Biochem Pharmacol; 2010 Nov 15; 80(10):1528-36. PubMed ID: 20723540 [Abstract] [Full Text] [Related]